Trang kết quả 2 cho Khu vực: Chăm sóc sức khỏe Ngành: Nhà sản xuất thuốc - Chung Thị trường chứng khoán - Báo giá & giá
Danh sách tất cả các chứng khoán và vốn chủ sở hữu kèm giá, vốn hoá thị trường, PE và EPS
Tất cả các quốc gia
- {{country.name}}
- Tất cả các quốc gia
- Hoa Kỳ (50)
- Argentina (13)
- Úc (1)
- Áo (13)
- Brazil (14)
- Canada (2)
- Chile (4)
- Trung Quốc (22)
- Phần Lan (2)
- Pháp (3)
- Đức (58)
- Hồng Kông (4)
- Hungary (1)
- Ấn Độ (20)
- Indonesia (1)
- Ý (5)
- Nhật Bản (9)
- Mexico (14)
- Singapore (1)
- Hàn Quốc (3)
- Tây Ban Nha (1)
- Thụy Điển (3)
- Thụy Sĩ (6)
- Đài Loan (1)
- Thổ Nhĩ Kỳ (1)
- Vương quốc Anh (20)
Tất cả các sàn giao dịch
- {{item.name}}
- Tất cả các sàn giao dịch
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
Chăm sóc sức khỏe (279)
- {{item.name}}
- Tất cả các khối
- Chăm sóc sức khỏe (279)
Nhà sản xuất thuốc - Chung (279)
- {{item.name}}
- Tất cả các ngành
- Công nghệ sinh học (2611)
- Nhà sản xuất thuốc - Chung (279)
- Nhà sản xuất thuốc - Biệt dược & Thuốc gốc (1705)
- Gói y tế (57)
- Cơ sơ chăm sóc y tế (553)
- Nhà bán lẻ thuốc (155)
- Dịch vụ thông tin sức khỏe (419)
- Thiết bị y tế (913)
- Thiết bị & nguồn cung y tế (501)
- Chẩn đoán & nghiên cứu (427)
- Phân phối y tế (138)
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS |
|---|
| Tên Tên | Giá Giá |
% 24h Biểu đồ 7n 24h% & 7n |
Vốn hoá TT Vốn hóa thị trường | KH. LƯỢNG Khối lượng | Đáy 24h | Đỉnh 24h | Vốn hóa thị trường | Tỉ lệ P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJ.BA | $14,050 16.61 USD |
+4.85
|
$413.24T 488.47B USD | $11.62K 13.74 USD | $13,750 16.25 USD | $14,125 16.7 USD | $413.24T 488.47B USD | 11.31 | $1.24K 1.47 USD | |
| Johnson & Johnson JNJ.MX | $3,192 189.01 USD |
+0.3
|
$7.81T 462.68B USD | $661 39.14 USD | $3,182.17 188.42 USD | $3,192.01 189.01 USD | $7.81T 462.68B USD | 27.17 | $117.47 6.96 USD | |
| AbbVie Inc. ABBV.BA | $26,575 31.41 USD |
-1.39
|
$389.44T 460.33B USD | $476 0.56 USD | $26,500 31.32 USD | $27,175 32.12 USD | $389.44T 460.33B USD | 10.36 | $2.56K 3.03 USD | |
| Johnson & Johnson JNJB34.SA | $60.02 12.17 USD |
+2.2
|
$2.18T 442.35B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.18T 442.35B USD | 27.53 | $2.18 0.44 USD | |
| AbbVie Inc. ABBV.MX | $4,028 238.51 USD |
-4.12
|
$7.24T 428.51B USD | $557 32.98 USD | $4,028 238.51 USD | $4,046 239.57 USD | $7.24T 428.51B USD | 83.32 | $48.34 2.86 USD | |
| AbbVie Inc. ABBV34.SA | $70.69 14.33 USD |
-2.71
|
$2.02T 409.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.02T 409.68B USD | 83.16 | $0.85 0.17 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| Johnson & Johnson JNJ.VI | $143.66 157.72 USD |
-0.6
|
$352.59B 385.43B USD | $489 364.01 USD | $144.12 157.54 USD | $144.78 158.26 USD | $352.59B 385.43B USD | 26.91 | $5.36 5.86 USD | |
| Johnson & Johnson JNJ.DE | $144.2 157.63 USD |
-0.36
|
$351.91B 384.69B USD | $3.14K 3.43K USD | $143.12 156.45 USD | $145.22 158.75 USD | $351.91B 384.69B USD | 27.15 | $5.31 5.8 USD | |
| Johnson & Johnson JNJ.F | $143.96 157.37 USD |
-0.46
|
$351.57B 384.31B USD | $303 331.22 USD | $142.5 155.77 USD | $145.24 158.77 USD | $351.57B 384.31B USD | 27.11 | $5.31 5.8 USD | |
| AbbVie Inc. ABBV.VI | $179.88 198.4 USD |
-2.36
|
$322.26B 352.28B USD | $0 0 USD | $181.4 198.29 USD | $181.5 198.4 USD | $322.26B 352.28B USD | 82.12 | $2.21 2.42 USD | |
| AbbVie Inc. 4AB.DE | $181.2 198.08 USD |
-1.86
|
$321B 350.9B USD | $1.48K 1.62K USD | $177.68 194.23 USD | $182.72 199.74 USD | $321B 350.9B USD | 82.36 | $2.2 2.4 USD | |
| AbbVie Inc. 4AB.F | $179.6 196.33 USD |
-2.59
|
$318.61B 348.29B USD | $134 146.48 USD | $179.6 196.33 USD | $182.48 199.48 USD | $318.61B 348.29B USD | 82.00 | $2.19 2.39 USD | |
| Roche Holding AG ROGN.MX | $6,690 396.13 USD |
0
|
$5.17T 305.87B USD | $43 2.55 USD | $0 0 USD | $0 0 USD | $5.17T 305.87B USD | 28.01 | $238.83 14.14 USD | |
| AstraZeneca PLC AZN.BA | $48,750 57.62 USD |
+2.74
|
$247.17T 292.17B USD | $275 0.33 USD | $48,700 57.57 USD | $49,450 58.45 USD | $247.17T 292.17B USD | 10.10 | $4.83K 5.7 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Novartis AG NVS.BA | $37,150 43.91 USD |
+3.34
|
$235.15T 277.96B USD | $235 0.28 USD | $37,075 43.82 USD | $37,500 44.33 USD | $235.15T 277.96B USD | 2.94 | $12.6K 14.89 USD | |
| Merck & Co., Inc. MRK.BA | $22,850 27.01 USD |
+0.11
|
$234.15T 276.77B USD | $1.64K 1.93 USD | $22,725 26.86 USD | $23,225 27.45 USD | $234.15T 276.77B USD | 0.31 | $72.32K 85.48 USD | |
| AstraZeneca PLC AZNN.MX | $1,490 88.23 USD |
-2.55
|
$4.67T 276.74B USD | $385 22.8 USD | $1,488 88.11 USD | $1,490 88.23 USD | $4.67T 276.74B USD | 32.68 | $45.59 2.7 USD | |
| AstraZeneca PLC A1ZN34.SA | $69.71 14.13 USD |
-2.59
|
$1.31T 264.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.31T 264.59B USD | 32.72 | $2.13 0.43 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.45T 263.29B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.45T 263.29B USD | 18.76 | $119.13 7.05 USD | |
| Merck & Co., Inc. MRK.MX | $1,722 101.96 USD |
-2.77
|
$4.43T 262.16B USD | $739 43.76 USD | $1,720 101.85 USD | $1,762.7 104.37 USD | $4.43T 262.16B USD | 12.59 | $136.73 8.1 USD | |
| Roche Holding AG RHHVF | $324.14 — |
+0.23
|
$254.61B — | $1 — | $323.39 — | $323.39 — | $254.61B — | 27.77 | $11.67 — | |
| Roche Holding AG RHHBF | $341.8 — |
0
|
$254.61B — | $200 — | $350 — | $350 — | $254.61B — | 29.31 | $11.66 — | |
| Novartis AG N1VS34.SA | $62.73 12.71 USD |
0
|
$1.24T 251.72B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.24T 251.72B USD | 18.89 | $3.32 0.67 USD | |
| Roche Holding AG RHO6.F | $35.8 39.13 USD |
-1.65
|
$229.63B 251.02B USD | $412 450.37 USD | $35.8 39.13 USD | $35.8 39.13 USD | $229.63B 251.02B USD | 26.51 | $1.35 1.48 USD | |
| Merck & Co., Inc. MRCK34.SA | $61.12 12.39 USD |
-2.83
|
$1.24T 250.64B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.24T 250.64B USD | 12.81 | $4.77 0.97 USD | |
| Merck & Co., Inc. MRK.SN | $96.42 — |
-25.14
|
$243.56B — | $0 — | $0 — | $0 — | $243.56B — | 14.30 | $6.74 — | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| AstraZeneca PLC AZNCF | $150.84 — |
0
|
$233.83B — | $200 — | $146.75 — | $146.75 — | $233.83B — | 33.52 | $4.5 — | |
| AstraZeneca PLC ZEGA.F | $66 72.15 USD |
-0.75
|
$209.66B 229.19B USD | $5 5.47 USD | $66 72.15 USD | $67 73.24 USD | $209.66B 229.19B USD | 32.03 | $2.06 2.25 USD | |
| AstraZeneca PLC ZEG.F | $130.25 142.38 USD |
-5.13
|
$201.91B 220.72B USD | $34 37.17 USD | $130.25 142.38 USD | $134.15 146.64 USD | $201.91B 220.72B USD | 31.53 | $4.13 4.51 USD | |
| Merck & Co., Inc. 6MK.F | $77.8 85.05 USD |
-0.89
|
$198.33B 216.8B USD | $240 262.35 USD | $77.8 85.05 USD | $78.1 85.37 USD | $198.33B 216.8B USD | 12.58 | $6.18 6.76 USD | |
| Merck & Co., Inc. MRK.VI | $77.3 85.37 USD |
-2.28
|
$197.58B 215.99B USD | $0 0 USD | $77.9 85.16 USD | $78.1 85.37 USD | $197.58B 215.99B USD | 12.51 | $6.24 6.82 USD | |
| Novartis AG NOTA.F | $99 108.22 USD |
-2.46
|
$196.03B 214.28B USD | $13 14.21 USD | $99 108.22 USD | $99 108.22 USD | $196.03B 214.28B USD | 18.40 | $5.38 5.88 USD | |
| Amgen Inc. AMGN.BA | $13,575 16.05 USD |
+1.12
|
$178.6T 211.11B USD | $568 0.67 USD | $13,475 15.93 USD | $13,650 16.13 USD | $178.6T 211.11B USD | 0.33 | $40.56K 47.94 USD | |
| Amgen Inc. AMGN.MX | $6,430 380.73 USD |
0
|
$3.45T 204.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.45T 204.53B USD | 41.84 | $153.68 9.1 USD | |
| Amgen Inc. AMGN34.SA | $61.69 12.5 USD |
-0.26
|
$933.49B 189.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $933.49B 189.2B USD | 40.32 | $1.53 0.31 USD | |
| Gilead Sciences, Inc. GILD.BA | $37,000 43.74 USD |
+1.44
|
$150.33T 177.7B USD | $551 0.65 USD | $36,975 43.71 USD | $37,700 44.56 USD | $150.33T 177.7B USD | 90.90 | $407 0.48 USD | |
| Pfizer Inc. PFE.BA | $8,030 9.49 USD |
-0.37
|
$150.3T 177.66B USD | $15.1K 17.85 USD | $8,000 9.46 USD | $8,220 9.72 USD | $150.3T 177.66B USD | 2.65 | $3.03K 3.58 USD | |
| Amgen Inc. AMG.F | $278.05 303.95 USD |
+1.48
|
$154.9B 169.32B USD | $32 34.98 USD | $276.5 302.25 USD | $278.05 303.95 USD | $154.9B 169.32B USD | 40.12 | $6.93 7.58 USD | |
| Amgen Inc. AMG.DE | $281.6 307.83 USD |
+1.17
|
$154.42B 168.8B USD | $413 451.46 USD | $279.05 305.04 USD | $281.9 308.15 USD | $154.42B 168.8B USD | 40.63 | $6.93 7.58 USD | |
| Pfizer Inc. PFE.MX | $487.2 28.85 USD |
-3.27
|
$2.85T 168.67B USD | $4.49K 266.04 USD | $485 28.72 USD | $503.02 29.78 USD | $2.85T 168.67B USD | 17.03 | $28.6 1.69 USD | |
| Amgen Inc. AMGN.VI | $281.6 307.23 USD |
+1.2
|
$154.18B 168.53B USD | $145 158.5 USD | $278.2 304.11 USD | $281.05 307.23 USD | $154.18B 168.53B USD | 40.09 | $7.01 7.66 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,278 134.89 USD |
0
|
$2.84T 168.15B USD | $184 10.9 USD | $0 0 USD | $0 0 USD | $2.84T 168.15B USD | 293.93 | $7.75 0.46 USD | |
| Gilead Sciences, Inc. GILD34.SA | $320.15 64.89 USD |
+1.31
|
$798.22B 161.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $798.22B 161.79B USD | 293.71 | $1.09 0.22 USD | |
| Pfizer Inc. PFIZ34.SA | $34.07 6.91 USD |
-2.68
|
$780.64B 158.22B USD | $0 0 USD | $0 0 USD | $0 0 USD | $780.64B 158.22B USD | 17.03 | $2 0.41 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$149.59B — | $0 — | $95.78 — | $95.78 — | $149.59B — | 252.05 | $0.38 — | |
| Bristol-Myers Squibb Company BMY.BA | $25,375 29.99 USD |
-2.4
|
$126.23T 149.21B USD | $1K 1.18 USD | $25,325 29.93 USD | $26,075 30.82 USD | $126.23T 149.21B USD | 0 | -$4,732 -5.5 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Bristol-Myers Squibb Company BMY.MX | $1,213 71.82 USD |
0
|
$2.47T 146.15B USD | $9 0.53 USD | $0 0 USD | $0 0 USD | $2.47T 146.15B USD | 0 | -$89.51 -5.3 USD | |
| Gilead Sciences, Inc. GIS.DE | $102.86 112.44 USD |
-0.35
|
$128.23B 140.17B USD | $2.76K 3.02K USD | $100.66 110.03 USD | $103.88 113.55 USD | $128.23B 140.17B USD | 293.88 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GILD.VI | $102.16 112.09 USD |
-0.78
|
$127.96B 139.87B USD | $53 18.58 USD | $101.4 110.84 USD | $102.54 112.09 USD | $127.96B 139.87B USD | 292.97 | $0.35 0.38 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $329.29 66.74 USD |
-3
|
$689.35B 139.72B USD | $0 0 USD | $0 0 USD | $0 0 USD | $689.35B 139.72B USD | 0 | -$24.98 -5.06 USD | |
| Gilead Sciences, Inc. GIS.F | $101.78 111.26 USD |
-1.26
|
$126.88B 138.7B USD | $262 286.4 USD | $101.18 110.6 USD | $101.86 111.35 USD | $126.88B 138.7B USD | 290.80 | $0.35 0.38 USD | |
| Pfizer Inc. PFEB.F | $6.9 7.54 USD |
-1.43
|
$124.52B 136.12B USD | $500 546.57 USD | $6.9 7.54 USD | $6.9 7.54 USD | $124.52B 136.12B USD | 15.68 | $0.44 0.48 USD | |
| Pfizer Inc. PFE.VI | $21.47 23.99 USD |
-4.19
|
$124.46B 136.05B USD | $1.44K 923.7 USD | $21.8 23.83 USD | $22.08 24.13 USD | $124.46B 136.05B USD | 16.75 | $1.31 1.43 USD | |
| Sanofi SNYNF | $109.84 — |
-6.68
|
$134.45B — | $291 — | $109.84 — | $109.84 — | $134.45B — | 23.22 | $4.73 — | |
| Sanofi SNW2.F | $49.6 54.22 USD |
-1.78
|
$121.42B 132.73B USD | $100 109.31 USD | $49.2 53.78 USD | $49.6 54.22 USD | $121.42B 132.73B USD | 22.54 | $2.2 2.4 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Sanofi SNW.F | $98.2 107.35 USD |
-1.51
|
$120.21B 131.41B USD | $48 52.47 USD | $98.2 107.35 USD | $99.72 109.01 USD | $120.21B 131.41B USD | 22.36 | $4.39 4.8 USD | |
| Sanofi SANO.VI | $96.79 105.83 USD |
-2.75
|
$118.72B 129.78B USD | $171 186.93 USD | $96.81 105.83 USD | $98.4 107.56 USD | $118.72B 129.78B USD | 22.05 | $4.39 4.8 USD | |
| GSK plc GSK.BA | $12,875 15.22 USD |
+3.83
|
$104.6T 123.64B USD | $893 1.06 USD | $12,675 14.98 USD | $12,900 15.25 USD | $104.6T 123.64B USD | 29.58 | $435.17 0.51 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $51.44 56.47 USD |
-6.1
|
$105.12B 114.91B USD | $0 0 USD | $51.66 56.47 USD | $51.79 56.61 USD | $105.12B 114.91B USD | 0 | -$4.08 -4.4 USD | |
| Bristol-Myers Squibb Company BRM.F | $51.43 56.22 USD |
-4.07
|
$104.65B 114.39B USD | $10 10.93 USD | $51.34 56.12 USD | $51.43 56.22 USD | $104.65B 114.39B USD | 0 | -$4.04 -4.4 USD | |
| Bristol-Myers Squibb Company BRM.DE | $51.09 55.85 USD |
-5.02
|
$103.96B 113.64B USD | $5.71K 6.24K USD | $51.09 55.85 USD | $52.19 57.05 USD | $103.96B 113.64B USD | 0 | -$4.05 -4.4 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $811 48.02 USD |
0
|
$1.65T 97.53B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.65T 97.53B USD | 24.62 | $32.93 1.95 USD | |
| GSK plc G1SK34.SA | $43.24 8.76 USD |
+1.31
|
$440.06B 89.19B USD | $0 0 USD | $0 0 USD | $0 0 USD | $440.06B 89.19B USD | 23.50 | $1.84 0.37 USD | |
| GSK GLAXF | $18.81 — |
0
|
$76.41B — | $107 — | $20.12 — | $20.16 — | $76.41B — | 23.51 | $0.8 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $40.09 43.82 USD |
+1.85
|
$68.87B 75.29B USD | $33 36.07 USD | $40.09 43.82 USD | $40.24 43.99 USD | $68.87B 75.29B USD | 27.45 | $1.46 1.6 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $22.33 24.41 USD |
+0.04
|
$42.11B 46.03B USD | $2K 2.19K USD | $22.33 24.41 USD | $22.33 24.41 USD | $42.11B 46.03B USD | 27.91 | $0.8 0.87 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $46.8 51.16 USD |
0
|
$25.31B 27.66B USD | $420 459.12 USD | $46.8 51.16 USD | $46.8 51.16 USD | $25.31B 27.66B USD | 11.90 | $3.93 4.3 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $417.75B 24.74B USD | 12.57 | $226.89 13.43 USD | |
| Biogen Inc. BIIB.BA | $13,225 15.63 USD |
-0.19
|
$20.53T 24.27B USD | $516 0.61 USD | $13,175 15.57 USD | $13,350 15.78 USD | $20.53T 24.27B USD | 1.10 | $12K 14.18 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $8,310 22.98 USD |
-4.48
|
$8.16T 22.58B USD | $91 0.25 USD | $8,310 22.98 USD | $8,600 23.79 USD | $8.16T 22.58B USD | 0 | -$1,045.7 -2.8 USD | |
| Bayer Aktiengesellschaft BAYA.F | $5.1 5.57 USD |
-1.92
|
$20.49B 22.4B USD | $35 38.26 USD | $5.1 5.57 USD | $5.1 5.57 USD | $20.49B 22.4B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. BIIB34.SA | $122.52 24.83 USD |
-10.57
|
$108.42B 21.97B USD | $0 0 USD | $0 0 USD | $0 0 USD | $108.42B 21.97B USD | 11.65 | $10.51 2.13 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $20.1 21.97 USD |
-5.55
|
$19.74B 21.58B USD | $1.55K 1.69K USD | $20.1 21.97 USD | $21.18 23.15 USD | $19.74B 21.58B USD | 0 | -$2.6 -2.8 USD | |
| Biogen Inc. IDP.F | $117.35 128.28 USD |
+0.69
|
$17.67B 19.31B USD | $19 20.77 USD | $117.35 128.28 USD | $117.35 128.28 USD | $17.67B 19.31B USD | 11.43 | $10.26 11.22 USD | |
| Biogen Inc. BIIB.VI | $117.65 128.61 USD |
-0.42
|
$17.47B 19.1B USD | $0 0 USD | $117.4 128.33 USD | $117.65 128.61 USD | $17.47B 19.1B USD | 11.35 | $10.36 11.32 USD | |
| Biogen Inc. IDP.DE | $116.9 127.79 USD |
-1.31
|
$17.32B 18.93B USD | $143 156.32 USD | $116.85 127.73 USD | $118.2 129.21 USD | $17.32B 18.93B USD | 11.39 | $10.26 11.22 USD | |
| Astellas Pharma Inc. YPH.F | $8.47 9.26 USD |
+3.93
|
$15.87B 17.34B USD | $27 29.51 USD | $8.47 9.26 USD | $8.47 9.26 USD | $15.87B 17.34B USD | 0 | -$0.2 -0.2 USD | |
| Astellas Pharma Inc. YPHA.F | $8.35 9.13 USD |
+3.73
|
$15.84B 17.31B USD | $0 0 USD | $8.35 9.13 USD | $8.35 9.13 USD | $15.84B 17.31B USD | 0 | -$0.2 -0.2 USD | |
| Astellas Pharma ALPMF | $9.45 — |
0
|
$16.92B — | $1K — | $9.45 — | $9.45 — | $16.92B — | 0 | -$0.21 — | |
| Cipla Limited CIPLA.BO | $1,415.55 17.13 USD |
-5.32
|
$1.14T 13.83B USD | $52.09K 630.17 USD | $1,390.35 16.82 USD | $1,499.25 18.14 USD | $1.14T 13.83B USD | 22.92 | $61.75 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $51.4 56.19 USD |
+0.59
|
$10.64B 11.63B USD | $40 43.73 USD | $51.3 56.08 USD | $51.4 56.19 USD | $10.64B 11.63B USD | 25.82 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $51.3 56.08 USD |
-0.39
|
$10.57B 11.55B USD | $0 0 USD | $51.3 56.08 USD | $51.7 56.52 USD | $10.57B 11.55B USD | 25.77 | $1.99 2.18 USD | |
| Orion Oyj ORINY | $31.1 — |
+0.13
|
$8.48B — | $248 — | $31.06 — | $31.06 — | $8.48B — | 24.48 | $1.27 — | |
| Orion Oyj OFK0.F | $26.8 29.3 USD |
-0.74
|
$7.72B 8.44B USD | $0 0 USD | $26.8 29.3 USD | $26.8 29.3 USD | $7.72B 8.44B USD | 22.90 | $1.17 1.28 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $2.36 2.58 USD |
+2.61
|
$7.65B 8.36B USD | $750 819.85 USD | $2.36 2.58 USD | $2.36 2.58 USD | $7.65B 8.36B USD | 12.42 | $0.19 0.21 USD | |
| Orion Oyj OFK.F | $53.06 58 USD |
-3.7
|
$7.49B 8.19B USD | $25 27.33 USD | $53.06 58 USD | $54.28 59.34 USD | $7.49B 8.19B USD | 22.57 | $2.35 2.57 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.63 0.69 USD |
-0.41
|
$7.42B 8.11B USD | $23K 25.14K USD | $0.5999 0.66 USD | $0.63 0.69 USD | $7.42B 8.11B USD | 12.54 | $0.05 0.05 USD | |
| CSPC Pharmaceutical CHJTF | $0.56 — |
0
|
$8.1B — | $11K — | $0.93 — | $0.9499 — | $8.1B — | 11.19 | $0.05 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $13.2 14.43 USD |
+5.6
|
$7.26B 7.94B USD | $254 277.66 USD | $13.2 14.43 USD | $13.2 14.43 USD | $7.26B 7.94B USD | 18.85 | $0.7 0.77 USD | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$7.72B — | $316 — | $14.75 — | $14.75 — | $7.72B — | 19.40 | $0.76 — | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Abbott India Limited ABBOTINDIA.NS | $29,077.4 351.79 USD |
-2.78
|
$618.52B 7.48B USD | $9.17K 110.89 USD | $28,829.15 348.78 USD | $30,090.55 364.05 USD | $618.52B 7.48B USD | 46.29 | $628.1 7.6 USD | |
| Abbott India Limited ABBOTINDIA.BO | $29,049.1 351.45 USD |
-2.98
|
$617.27B 7.47B USD | $588 7.11 USD | $28,822.15 348.7 USD | $29,998.75 362.93 USD | $617.27B 7.47B USD | 46.20 | $628.75 7.61 USD | |
|
Không có cổ phiếu ưa thích
Bạn chưa có cổ phiếu ưa thích nào, hãy thêm nó vào mục ưa thích để thấy nó tại đây |
||||||||||
- {{ link.label }} {{link}}